To detect early changes of hydroxy chloroquine retinal toxicity by using Fundus auto fluorescence and spectral domain optical coherence tomography
Not Applicable
- Conditions
- Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
- Registration Number
- CTRI/2022/07/044415
- Lead Sponsor
- sankara Eye Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who are taking hydroxychloroquine for atleast 2 years for,
RA,
SLE,
Sjogrenâ??s syndrome,
Other connective tissue diseases
Exclusion Criteria
Anterior segment disease,
Glaucoma,
Nystagmus,
Retinal disease especially macular pathology
History of vitreoretinal surgery
Media opacity preventing fundus view
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method